Figure 8.
Effect of ligustrazine on the PI3K/Akt signaling pathway. LY: LY294002; CME: coronary microembolization. aP < 0.05 compared to the sham group. bP < 0.05 compared to the CME group. n = 10.
Effect of ligustrazine on the PI3K/Akt signaling pathway. LY: LY294002; CME: coronary microembolization. aP < 0.05 compared to the sham group. bP < 0.05 compared to the CME group. n = 10.